Senzime AB (publ)

Symbol: SEZI.ST




Market price today

  • -4.5622

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 577.25M

    MRK Cap

  • 0.00%

    DIV Yield

Senzime AB (publ) (SEZI-ST) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Medical Devices
CEO:Mr. Philip Siberg
Full-time employees:45
Address:Ulls vAeg 41

Senzime AB (publ), a medical device company, develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States. The company offers TetraGraph, a monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; TetraSens electrode array, which has two proximal stimulating electrodes for recording and reference; TetraConnect, a data management portal that helps clinician to access, view, and export data records from the TetraGraph in PDF or Excel format; TetraGraph Device Connectivity, which transfers data from the TetraGraph Monitor to patient monitoring systems; and TetraGraph Philips Interface that enables the transmission of neuromuscular monitoring parameters, TOFC, TOFR, PTC, and TOF bars to Philips patient monitors, as well as TetraGraph readings are displayed on the Philips Intellivue Monitor. It also develops CliniSenz Analyzer for postoperative and continuous patient monitoring in hospital environments; and Onzurf Probe, a sterile CE-marked single use product based on micro-dialysis technology that enables continuous sampling from gastro-intestinal organs, such as esophagus, stomach, and liver. Senzime AB (publ) has a strategic license and connectivity agreement with Masimo to develop and market the TetraGraph Smart Cable Module that connects directly to Root monitoring system, as well as to their digital hubs to interface with the hospital clinical information system/electronic health records. The company was incorporated in 1999 and is based in Uppsala, Sweden.

General Outlook

In simple terms, Senzime AB (publ) has 105.122 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.240% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -4.756%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -3.912%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.315% return, is a testament to Senzime AB (publ)'s adeptness in optimizing resource deployment. Senzime AB (publ)'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.395%. Furthermore, the proficiency of Senzime AB (publ) in capital utilization is underscored by a remarkable -0.407% return on capital employed.

Stock Prices

Senzime AB (publ)'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $6.74, while its low point bottomed out at $6.1. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Senzime AB (publ)'s stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2023?

There are stock number shares outstanding of Senzime AB (publ) (SEZI.ST) on the STO in 2023.

What is P/E ratio of enterprise in 2023?

The current P/E ratio of enterprise is -4.562 in 2023.

What is the ticker symbol of Senzime AB (publ) stock?

The ticker symbol of Senzime AB (publ) stock is SEZI.ST.

What is company IPO date?

IPO date of Senzime AB (publ) is 2008-06-18.

What is company current share price?

Current share price is 5.740 SEK.

What is stock market cap today?

The market cap of stock today is 577254580.000.

What is PEG ratio in 2023?

The current 0.000 is 0.000 in 2023.

What is the number of employees in 2023?

In 2023 the company has 45.